137 related articles for article (PubMed ID: 7774891)
1. p53 expression and DNA ploidy of cartilage lesions.
Coughlan B; Feliz A; Ishida T; Czerniak B; Dorfman HD
Hum Pathol; 1995 Jun; 26(6):620-4. PubMed ID: 7774891
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
3. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J
Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439
[TBL] [Abstract][Full Text] [Related]
4. DNA flow cytometric analysis of chest-wall chondroma and chondrosarcoma.
Shih CS; Wang LS; Yang SS; Fahn HJ; Wu LH; Chen WY; Huang MH
Scand J Thorac Cardiovasc Surg; 1996; 30(3-4):157-61. PubMed ID: 8976036
[TBL] [Abstract][Full Text] [Related]
5. Cell proliferation studies in primary synovial chondromatosis.
Davis RI; Foster H; Arthur K; Trewin S; Hamilton PW; Biggart DJ
J Pathol; 1998 Jan; 184(1):18-23. PubMed ID: 9582522
[TBL] [Abstract][Full Text] [Related]
6. Possible association of p53 overexpression and mutation with high-grade chondrosarcoma.
Dobashi Y; Sugimura H; Sato A; Hirabayashi T; Kanda H; Kitagawa T; Kawaguchi N; Imamura T; Machinami R
Diagn Mol Pathol; 1993 Dec; 2(4):257-63. PubMed ID: 8118603
[TBL] [Abstract][Full Text] [Related]
7. IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromas.
Damato S; Alorjani M; Bonar F; McCarthy SW; Cannon SR; O'Donnell P; Tirabosco R; Amary MF; Flanagan AM
Histopathology; 2012 Jan; 60(2):363-5. PubMed ID: 22074484
[No Abstract] [Full Text] [Related]
8. Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma.
Bovée JV; Cleton-Jansen AM; Kuipers-Dijkshoorn NJ; van den Broek LJ; Taminiau AH; Cornelisse CJ; Hogendoorn PC
Genes Chromosomes Cancer; 1999 Nov; 26(3):237-46. PubMed ID: 10502322
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging of cartilaginous tumors: a retrospective study of 79 patients.
De Beuckeleer LH; De Schepper AM; Ramon F; Somville J
Eur J Radiol; 1995 Nov; 21(1):34-40. PubMed ID: 8654456
[TBL] [Abstract][Full Text] [Related]
10. p53 expression in dedifferentiated chondrosarcoma.
Simms WW; Ordóñez NG; Johnston D; Ayala AG; Czerniak B
Cancer; 1995 Jul; 76(2):223-7. PubMed ID: 8625095
[TBL] [Abstract][Full Text] [Related]
11. [Matrix gene expression pattern as indicators of the biology of cartilage-forming tumors].
Aigner T; Unni CC; Bjornsson J; Kirchner T
Verh Dtsch Ges Pathol; 1998; 82():178-83. PubMed ID: 10095430
[TBL] [Abstract][Full Text] [Related]
12. Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes.
Rozeman LB; de Bruijn IH; Bacchini P; Staals EL; Bertoni F; Bovée JV; Hogendoorn PC
Mod Pathol; 2009 Nov; 22(11):1489-98. PubMed ID: 19734846
[TBL] [Abstract][Full Text] [Related]
13. [Determination of malignancy of cartilaginous tumors (2). Determination of malignancy by nuclear DNA contents and their distribution patterns in cartilaginous tumors].
Lin CP; Higaki S; Takeyama S; Nakata T; Akai M; Tateishi A; Abe M
Nihon Seikeigeka Gakkai Zasshi; 1983 Jun; 57(6):617-28. PubMed ID: 6619626
[TBL] [Abstract][Full Text] [Related]
14. [TP53 gene aberrations in chondromatous neoplasms: correlation with immunohistochemical p53 accumulation and MDM2 expression].
Blasenbreu S; Baretton GB; Bender C; Haas CJ; Diebold J; Löhrs U
Verh Dtsch Ges Pathol; 1998; 82():284-9. PubMed ID: 10095448
[TBL] [Abstract][Full Text] [Related]
15. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas.
Wadayama B; Toguchida J; Yamaguchi T; Sasaki MS; Yamamuro T
Br J Cancer; 1993 Dec; 68(6):1134-9. PubMed ID: 8260365
[TBL] [Abstract][Full Text] [Related]
16. p53 mutations in chondrosarcoma.
Terek RM; Healey JH; Garin-Chesa P; Mak S; Huvos A; Albino AP
Diagn Mol Pathol; 1998 Feb; 7(1):51-6. PubMed ID: 9646035
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis.
Bovée JV; Cleton-Jansen AM; Rosenberg C; Taminiau AH; Cornelisse CJ; Hogendoorn PC
J Pathol; 1999 Dec; 189(4):454-62. PubMed ID: 10629543
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value and limitations of fluorine-18 fluorodeoxyglucose positron emission tomography for cartilaginous tumors of bone.
Lee FY; Yu J; Chang SS; Fawwaz R; Parisien MV
J Bone Joint Surg Am; 2004 Dec; 86(12):2677-85. PubMed ID: 15590853
[TBL] [Abstract][Full Text] [Related]
19. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma?
Cheville JC; Wu K; Sebo TJ; Cheng L; Riehle D; Lohse CM; Shane V
Cancer; 2000 Feb; 88(3):632-6. PubMed ID: 10649258
[TBL] [Abstract][Full Text] [Related]
20. Rb-loss is associated with high malignancy in chondrosarcoma.
Röpke M; Boltze C; Meyer B; Neumann HW; Roessner A; Schneider-Stock R
Oncol Rep; 2006 Jan; 15(1):89-95. PubMed ID: 16328039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
